News + Filings Transactions
|
PALEKAR ROHAN
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/17/2023 | 89bio, Inc. | ETNB | Payment of Exercise | Common Stock | 4.5k | $15.46 | $69.6k | | 08/17/2023 |
| 06/30/2023 | 89bio, Inc. | ETNB | Grant | Common Stock | 33.3k | $0.00 | $0 | | 06/30/2023 |
| 06/30/2023 | 89bio, Inc. | ETNB | Payment of Exercise | Common Stock | 16.5k | $18.95 | $313.2k | | 06/30/2023 |
| 06/08/2023 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $0.79 | $19.8k | | 06/08/2023 |
| 06/05/2023 | 89bio, Inc. | ETNB | Sale | Common Stock | 15k | $20.00 | $300k | | 06/05/2023 |
| 06/05/2023 | 89bio, Inc. | ETNB | Exercise | Stock Option (Right to Buy) | 15k | $1.93 | $29k | | 06/05/2023 |
| 03/31/2023 | 89bio, Inc. | ETNB | Grant | Common Stock | 33.3k | $0.00 | $0 | | 03/31/2023 |
| 03/31/2023 | 89bio, Inc. | ETNB | Payment of Exercise | Common Stock | 15.4k | $15.23 | $235.2k | | 03/31/2023 |
| 03/23/2023 | 89bio, Inc. | ETNB | Sale | Common Stock | 15k | $16.00 | $240k | | 03/23/2023 |
| 02/17/2023 | 89bio, Inc. | ETNB | Payment of Exercise | Common Stock | 6.3k | $13.97 | $87.7k | | 02/17/2023 |
| 02/05/2023 | 89bio, Inc. | ETNB | Payment of Exercise | Common Stock | 4.1k | $13.24 | $54k | | 02/05/2023 |
| 09/28/2022 | 89bio, Inc. | ETNB | Grant | Common Stock | 33.3k | $0.00 | $0 | | 09/28/2022 |
| 09/28/2022 | 89bio, Inc. | ETNB | Payment of Exercise | Common Stock | 11.5k | $5.76 | $66.4k | | 09/28/2022 |
| 09/08/2022 | 89bio, Inc. | ETNB | Exercise | Stock Option (Right to Buy) | 100k | $1.93 | $193k | | 09/08/2022 |
| 05/12/2022 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $1.07 | $26.8k | | 05/12/2022 |
| 03/02/2022 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 50k | $2.72 | $136k | | 03/02/2022 |
| 02/17/2022 | 89bio, Inc. | ETNB | Grant | Common Stock | 54.2k | $0.00 | $0 | | 02/17/2022 |
| 02/17/2022 | 89bio, Inc. | ETNB | Grant | Stock Option (Right to Buy) | 220k | $4.44 | $976.8k | | 02/17/2022 |
| 02/05/2022 | 89bio, Inc. | ETNB | Payment of Exercise | Common Stock | 4.1k | $5.23 | $21.4k | | 02/05/2022 |
| 01/28/2022 | 89bio, Inc. | ETNB | Purchase | Common Stock | 2.5k | $6.14 | $15.4k | | 01/27/2022 |
| 01/27/2022 | 89bio, Inc. | ETNB | Purchase | Common Stock | 5k | $7.50 | $37.5k | | 01/27/2022 |
| 07/08/2021 | 89bio, Inc. | ETNB | Purchase | Common Stock | 2k | $16.25 | $32.5k | | 07/07/2021 |
| 07/07/2021 | 89bio, Inc. | ETNB | Purchase | Common Stock | 5k | $17.07 | $85.4k | | 07/07/2021 |
| 02/05/2021 | 89bio, Inc. | ETNB | Grant | Stock Option (Right to Buy) | 203.8k | $23.01 | $4.7M | | 02/05/2021 |
| 02/05/2021 | 89bio, Inc. | ETNB | Grant | Common Stock | 30k | $0.00 | $0 | | 02/05/2021 |
| 02/14/2020 | 89bio, Inc. | ETNB | Grant | Stock Option (Right to Buy) | 170k | $32.50 | $5.5M | | 02/14/2020 |
| 11/28/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 15k | $15.00 | $225k | | 11/28/2014 |
| 11/28/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock Option (right to buy) | 15k | $3.38 | $50.7k | | 11/28/2014 |
| 11/10/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Grant | Common Stock | 59.2k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Grant | Common Stock | 34.8k | $0.00 | $0 | | 11/10/2014 |
| 09/15/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 10k | $10.00 | $100k | | 09/15/2014 |
| 09/15/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Sale | Common Stock | 15k | $12.50 | $187.5k | | 09/15/2014 |
| 09/15/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Exercise | Stock Option (right to Buy) | 25k | $3.38 | $84.5k | | 09/15/2014 |
| 02/12/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Grant | Common Stock | 80.8k | $0.00 | $0 | | 02/12/2014 |
| 02/12/2014 | AVANIR PHARMACEUTICALS, INC. | AVNR | Grant | Common Stock | 43k | $0.00 | $0 | | 02/12/2014 |
|
|